ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,285Medicare Part D Prescriptions Filled, Including Refills

Rank: 55 out of 1844

$757K Total Retail Price of All Prescriptions

Rank: 119 out of 1844

667 Patients Receiving at Least One Drug in Part D
77%Patients 65 Years and Older
50% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 667 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

20% of this provider’s 667 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

1% of this provider’s 12,572 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
LEVOTHYROXINE SODIUM 812 704 1 1
HYDROCODONE-ACETAMINOPHEN 717 476 S3 2 2
FUROSEMIDE 570 431 3 7
SIMVASTATIN 542 418 4 3
LISINOPRIL 385 258 5 4
OMEPRAZOLE 373 321 6 5
METOPROLOL TARTRATE 327 241 7 11
POTASSIUM CHLORIDE 293 224 8 16
CITALOPRAM HBR 262 226 9 19
METOPROLOL SUCCINATE 256 190 10 14
ALLOPURINOL 255 166 11 29
AMLODIPINE BESYLATE 243 189 12 6
ATENOLOL 230 208 13 17
CLOPIDOGREL 226 198 14 34
CARVEDILOL 216 194 15 22
METFORMIN HCL ER 215 168 16 46
RANITIDINE HCL 210 142 17 38
CEPHALEXIN 201 128 18 56
PRAVASTATIN SODIUM 200 142 19 10
TRIAMTERENE-HCTZ 188 151 20 48
WARFARIN SODIUM 184 109 21 13
METFORMIN HCL 166 94 22 8
DONEPEZIL HCL 165 165 23 26
GLIPIZIDE ER 155 122 24 79
FAMOTIDINE 149 127 25 63
PLAVIX 145 122 26 61
LANTUS 138 119 27 42
GABAPENTIN 137 98 28 15
SERTRALINE HCL 135 103 29 21
MIRTAZAPINE 135 106 29 49
PREDNISONE 135 121 29 40
ATORVASTATIN CALCIUM 131 110 32 12
DIGOXIN 129 125 33 67
PANTOPRAZOLE SODIUM 128 96 34 32
FLUOXETINE HCL 126 83 35 41
ZOLPIDEM TARTRATE 122 93 36 23
GLIPIZIDE 110 69 37 70
POLYETHYLENE GLYCOL 3350 106 103 38 39
LISINOPRIL-HYDROCHLOROTHIAZIDE 104 60 39 20
TRAMADOL HCL 102 75 40 18
NEXIUM 99 86 41 31
ISOSORBIDE MONONITRATE ER 98 96 42 59
MELOXICAM 96 85 43 28
SYNTHROID 90 86 44 55
CYMBALTA 85 60 45 36
HYDROCHLOROTHIAZIDE 85 67 45 9
METOLAZONE 80 64 47 209
GEMFIBROZIL 79 76 48 108
ENALAPRIL MALEATE 78 65 49 69
KLOR-CON 10 78 52 49 123
LOSARTAN POTASSIUM 78 62 49 24
TAMSULOSIN HCL 74 64 52 27
NAMENDA 72 72 53 33
SPIRONOLACTONE 70 47 54 60
METOCLOPRAMIDE HCL 69 23 55 148
TRIAMCINOLONE ACETONIDE 66 38 56 153
BUMETANIDE 65 29 57 121
AZITHROMYCIN 64 51 58 37
CYCLOBENZAPRINE HCL 61 19 R 59 53
ALENDRONATE SODIUM 60 38 60 25
SULFAMETHOXAZOLE-TRIMETHOPRIM 59 43 61 73
OXYBUTYNIN CHLORIDE ER 58 47 62 126
JANUVIA 58 45 62 77
HUMALOG 58 45 62 114
FLUTICASONE PROPIONATE 58 45 62 50
NYSTATIN 57 50 66 85
PAROXETINE HCL 56 53 67 68
METHOCARBAMOL 56 32 R 67 241
DILTIAZEM HCL 55 53 69 221
GLIPIZIDE XL 55 26 69 220
RISPERIDONE 55 50 69 65
AMITRIPTYLINE HCL 54 41 R 72 72
LEVETIRACETAM 54 36 72 105
AMOX TR-POTASSIUM CLAVULANATE 53 42 74 139
FENTANYL 53 53 S2 74 66
CRESTOR 53 30 74 30
VESICARE 51 51 77 182
LANTUS SOLOSTAR 50 43 78 97
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 18, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.